Megavitamin and dietary treatment in schizophrenia: A randomised, controlled trial

Australian and New Zealand Journal of Psychiatry

Volumn 33, Issue 1, 1999, Pages 84-88

  Vaughan, Kevin ^a   McConaghy, Nathaniel ^b  

^a Hornsby Hospital   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Megavitamin; Schizophrenia; Treatment trial

Indexed keywords

ASCORBIC ACID; MULTIVITAMIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; VITAMIN BLOOD LEVEL;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; ORTHOMOLECULAR THERAPY; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0033062010     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.1999.00527.x     Document Type: Article

References (28)

1. Vaughan K, Doyle M, McConaghy N, Blaszczynski A, Fox A, Tarrier N. The relationship between relative's expressed emotion and schizophrenic relapse: an Australian replication. Social Psychiatry and Psychiatric Epidemiology 1993; 27:10-15.
2. Vaughan K, Doyle M, McConaghy N, Blaszczynski A. Fox A, Tarrier N. The Sydney intervention trial: a controlled trial of relatives' counselling to reduce schizophrenic relapse. Social Psychiatry and Psychiatric Epidemiology 1993; 27:16-21.
3. Jorm AF, Korten AE, Jacomb PA, Christensen PA, Rodgers B. Medical Journal of Australia 1997; 166:182-186.
4. Pauling L. Orthomolecular psychiatry. Science 1997; 160:265-270.
5. Deutsch RM. The new nuts among the berries. Palo Alto, CA: Bull, 1977.
6. Task Force Report 7. Megavitamin and orthomolecular therapy in psychiatry. Washington, DC: American Psychiatric Association, 1973.
7. Orthomolecular psychiatry. Position Statement 24. Melbourne: Royal Australian and New Zealand College of Psychiatrists, 1988.
8. Hoffer A. Niacin therapy in psychiatry. Springfield, IL: C.C. Thomas, 1962.
9. Hoffer A, Osmond H. Nicotinamide Adenine Dinucleotide (NAD) as a treatment for schizophrenia. Journal of Psychopharmacology 1966; 1:78-95.
10. Denson R. The value of nicotinamide in the treatment of schizophrenia. Diseases of the Nervous System 1962; 23:167-172.
11. Whittenborn JR. A search for responders of niacin supplementation. Archives of General Psychiatry 1974; 31:547-552.
12. McGrath SD, O'Brien PF, Power PJ, Shea JR. Nicotinamide treatment of schizophrenia. Schizophrenia Bulletin 1972; 5:74-76.
13. Ashby WR, Collins GH, Bennet M. Effects of nicotinamide on the chronic schizophrenic. Journal of Mental Diseases 1972; 106:1555-1559.
14. Ban TA, Lehmann HE. Nicotinic acid in the treatment of schizophrenics Canadian Psychiatric Association Journal 1975; 20:103-112.
15. Sedhev A, Harchan S, Olson J. Nicotinic acid. Comprehensive Psychiatry 1974; 15:511-517.
16. Ban TA, Lehman HE, Deutsch M. Negative findings with megavitamins in schizophrenic patients: preliminary report. Communications in Psychopharmacology 1977; 1:119-122.
17. Herjanic M, Moss-Herjanic BL, Keith-Paul W. Treatment of schizophrenia with nicotinic acid. Journal of Schizophrenia 1967; 1:197-199.
18. Ananth JV, Ban TA, Lehmann HE. Potentiation of therapeutic effects of nicotinic acid by pyrodoxine in chronic schizophrenics. Canadian Psychiatric Association Journal 1973; 18:377-382.
19. Reading CM. Orthomolecular medicine and megavitamin therapy. Medical Journal of Australia 1979; 2:40.
20. Reading CM. Letter to the editor. Orthomolecular Psychiatry 1981; 10:29-34.
21. Wing JK, Cooper JE, Sartorious N. The Description and Classification of Psychiatric Symptoms: an instruction manual for PSE and CATEGO System. London: Cambridge University Press. 1974.
22. Derogatis LR, Melisaratos N. The Brief Symptom Inventory; an introductory report. Psychological Medicine 1983; 13:595-605.
23. Peterson DR. Behaviour problems in middle childhood. Journal of Consulting Psychology 1967; 25:205-209.
24. Creer C, Wing JK. Schizophrenia at home. National Schizophrenia Fellowship. Surliton: Surrey, 1974.
25. Wide I, Bennich H, Johansson SGO. Diagnosis of Allergy by an in-vitro test for allergen anti-bodies Lancet 1967; 2:1105-1106.
26. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports 1962; 10:799-812.
27. Brekke JS, Shelley L, Wolkon ES, Slade E. Psychosocial functioning and subjective experience in schizophrenia. Schizophrenia Bulletin 1993; 19:599-608.
28. McConaghy N. Lovibond SH. Methological formalism in psychiatric research. Journal of Nervous and Mental Diseases 1967; 144:117-123.